Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000436 · ClinicalTrials.gov registry record · Phase 3
Improving Functional Recovery After Hip Fracture
A Phase 3 study of Unilateral Hip Fracture, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00000436 is a Phase 3 study of Unilateral Hip Fracture that has completed, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00000436, a Phase 3 study of Unilateral Hip Fracture, has completed, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will assess the effectiveness of a novel approach involving patient education and strength training to improve functional recovery after a hip fracture. Participants will be randomly assigned to one of two study groups. One group (control group) will receive standard medical care. The other group will participate in a program of patient education and strength training, including an at-home walking program.
Conditions Studied
Interventions
- BEHAVIORAL Self-efficacy and muscle strength training
- PROCEDURE High-intensity strength training
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1993-07 |
| Est. Completion | 2000-06 |
| Phase | Phase 3 |
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)93 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000436
The ClinicalTrials.gov registry entry for NCT00000436 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Unilateral Hip Fracture appearing as the primary indexed condition, and to 2 interventions - of which Self-efficacy and muscle strength training is the first listed.
NCT00000436 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00000436 about?
NCT00000436 is a clinical study titled "Improving Functional Recovery After Hip Fracture". This project will assess the effectiveness of a novel approach involving patient education and strength training to improve functional recovery after a hip fracture. Participants will be randomly assigned to one of two study groups. One group (control group) will receive standard medical care. The o...
What is the current status of trial NCT00000436?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 1993-07. Estimated completion is 2000-06.
What conditions does trial NCT00000436 study?
This clinical trial studies the following conditions: Unilateral Hip Fracture.
What interventions are being tested in trial NCT00000436?
The interventions under investigation include: Self-efficacy and muscle strength training (BEHAVIORAL), High-intensity strength training (PROCEDURE).
Who is sponsoring clinical trial NCT00000436?
This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000436 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.